NCT00820300View on ClinicalTrials.gov

A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

Latanoprost-PPDS

Control of IOP compared to baseline for the experimental doses of Latanoprost-PPDS for 4 months or until loss of efficacy.

Trial Locations (1)

94025

Menlo Park

Sponsors
All Listed Sponsors
lead

Mati Therapeutics Inc.

INDUSTRY

NCT00820300 - A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma | Biotech Hunter | Biotech Hunter